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Background: Diabetes and its complications account for 10% of annual UK healthcare spending. Digital healthcare
interventions (DHIs) can provide scalable care, fostering diabetes self-management and reducing the risk of complications.
Tailorability and usability are key to DHI engagement/effectiveness. User-centred design of DHIs, aligning features to end
users’ needs, can generate more usable interventions, avoiding unintended consequences and improving user engagement.
Objective: MyDiabetesIQ is an Artificial Intelligence engine, intended to provide users with tailored forecasts of their diabetes
complications risk. It will underpin a user interface in which users will alter lifestyle parameters to see the impact this has on
future risks,. MyDiabetesIQ will link to an existing DHI, My Diabetes My Way (MDMW). We describe user-centred design,
informed by human factors engineering, of the user interface of MyDiabetesIQ.
Methods: Current users of MDMW were invited to take part in focus groups to gather their insights about users being shown
their complications risks, and any risks they perceived from using MyDiabetesIQ.  Findings from focus groups informed the
development of a prototype MyDiabetesIQ interface. The prototype was user tested through the ‘think aloud’ method, in which
users speak aloud about their thoughts/impressions while performing prescribed tasks. Focus group and think aloud transcripts
were analysed thematically (a combination of inductive and deductive analysis). For think aloud data, a sociotechnical model
was used as a framework for thematic analysis.
Results: Focus group participants (n=8) felt that some users could become anxious when shown their future complications risks.
They highlighted the importance of easy navigation, avoidance of jargon, and use of positive/encouraging language. User testing
of the prototype site through think aloud sessions (n=7) highlighted several usability issues. Issues included confusing visual
cues and confusion over whether user-updated information fed back to healthcare teams. Some issues could be compounded for
users with limited digital skills. Results of focus groups and think aloud workshops are being used in the development of a live
MyDiabetesIQ platform.
Conclusions: Acting on the input of end users at each iterative stage of development can help to prioritise users throughout the
design process, ensuring alignment of DHI features with their needs. Use of the sociotechnical framework encouraged
consideration of interactions between different sociotechnical dimensions in finding solutions to issues, for example avoiding the
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exclusion of users with limited digital skills. Based on user feedback, the tool could scaffold good goal setting, allowing users to
balance their palatable future complications risk against acceptable lifestyle changes. Good control of diabetes relies heavily on
self-management. Tools such as MDMW/MyDiabetesIQ can offer personalised support for self-management alongside access to
users’ electronic health records, potentially helping to delay or reduce long-term complications, thereby providing significant
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User-centred  design  of  a  novel  risk  prediction  behaviour  change  tool
augmented  with  an  Artificial  Intelligence  engine  (MyDiabetesIQ):  A
sociotechnical systems approach 
Abstract
Introduction
Diabetes  and  its  complications  account  for  10%  of  annual  UK  healthcare  spending.  Digital
healthcare interventions (DHIs) can provide scalable care, fostering diabetes self-management and
reducing the risk of complications. Tailorability (providing personalised interventions) and usability
are key to DHI engagement/effectiveness. User-centred design of DHIs,  aligning features to end
users’  needs,  can  generate  more  usable  interventions,  avoiding  unintended  consequences  and
improving user engagement. 
Objective
MyDiabetesIQ (MDIQ) is an Artificial Intelligence engine, intended to provide users with forecasts
of their own diabetes complications risk. It will underpin a user interface in which users will alter
lifestyle parameters to see the impact this has on their future risks. MDIQ will link to an existing
DHI, My Diabetes My Way (MDMW). We describe user-centred design, informed by human factors
engineering, of the user interface of MDIQ.
Methods
Current users of MDMW were invited to take part in focus groups to gather their insights about users
being  shown  their  likelihood  of  developing  diabetes-related complications,  and  any  risks  they
perceived from using MDIQ.  Findings from focus groups informed the development of a prototype
MDIQ interface, which was then user tested through the ‘think aloud’ method, in which users speak
aloud about their thoughts/impressions while performing prescribed tasks. Focus group and think
aloud transcripts were analysed thematically (a combination of inductive and deductive analysis).
For think aloud data, a sociotechnical model was used as a framework for thematic analysis.
Results 
Focus group participants (n=8) felt that some users could become anxious when shown their future
complications risks. They highlighted the importance of easy navigation, avoidance of jargon, and
use of positive/encouraging language. User testing of the prototype site through think aloud sessions
(n=7) highlighted several usability issues. Issues included confusing visual cues and confusion over
whether user-updated information fed back to healthcare teams. Some issues could be compounded
for users with limited digital skills. Results of focus groups and think aloud workshops were used in
the development of a live MDIQ platform. 
Conclusion
Acting on the input of end users at each iterative stage of a digital tool’s development can help to
prioritise users throughout the design process, ensuring alignment of DHI features with user needs.
Use of  the  sociotechnical  framework encouraged consideration  of  interactions  between different
sociotechnical dimensions in finding solutions to issues, for example avoiding the exclusion of users
with limited digital skills. Based on user feedback, the tool could scaffold good goal setting, allowing
users to balance their palatable future complications risk against acceptable lifestyle changes. Good
control  of  diabetes  relies  heavily on self-management.  Tools  such as  MDMW/ MDIQ can offer
personalised  support  for  self-management  alongside  access  to  users’ electronic  health  records,
potentially  helping  to  delay  or  reduce  long-term  complications  -  thereby  providing  significant
reductions in healthcare costs.
Keywords:
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Diabetes mellitus; Digital health intervention; eHealth; Artificial intelligence; User-centred design;
Human factors; Think aloud
Introduction
Diabetes is a chronic disease affecting an estimated 463 million adults worldwide  [1], with global
spending related to diabetes and its complications exceeding U.S.$800 billion annually  [2]. Good
control  of  diabetes  decreases  the  risk  of  chronic  associated  complications  [3].  Digital  health
interventions (DHIs), delivered through interactive websites and mobile apps, have the potential to
harness  the  omnipresence  and  growing  computational  power  of  electronic  devices  for  the  self-
management  of  chronic  diseases  [4-6].  Usability  and  ‘tailorability’ are  known  to  improve  user
acceptability  and  engagement  with  DHIs  [7,8] and  therefore,  potentially,  their  effectiveness.  A
relatively small number of studies has so far been published on DHI usability [9], partly due to many
such  interventions  being  developed  by  commercial  companies  [10].  Fewer  still  have  sought  to
include ‘end users’ in usability testing.
The UK government “Five Year Forward View” encourages and enables individuals to take greater
responsibility for their own health through use of eHealth/mHealth services [11], a sentiment that is
mirrored in  most developed nations.  This drive has become more pressing due to the impact of
COVID-19, which has altered care models for People with diabetes (PWD)[12], necessarily shifting
the focus towards remote care [13]. Diabetes is possibly the most amenable of all chronic conditions
to the use of  DHIs in scalable follow-up care [14,15].  Many of the challenges faced by people in
managing their diabetes occur “in the moments of everyday life” [15], when a DHI has the potential
to deliver targeted and timely assistance.  
Considering how crucial usability is for a DHI, it is concerning that a recent evaluation of four top-
rated  diabetes  apps  found that  all  suffered  from usability  problems,  many of  which  were  ‘very
serious’  [16]. User-centred design of health interventions explicitly involves end users in design,
development and evaluation [14,17]. This approach has the potential to produce more acceptable and
usable DHIs  [18] by ensuring from the outset that an intervention is targeted to end-users’ needs
[19,20].  The  use  of  iterative  design  cycles,  which  include  end  users  at  each  stage  of  product
development, is also recognised as being important in developing usable DHIs [10]. So too is gaining
a good understanding of the context in which specified users will interact with the product [21].
Sittig and Singh’s sociotechnical model  [22] was developed to allow the social context of a digital
healthcare tool to be linked to the technical component, and recognises that the two components
influence one another [23]. It has previously been adapted by others to examine a range of different
healthcare  technologies,  including  patient-facing  portals  and  health  apps  [24-26].  It  allows  for
different sociotechnical dimensions to be dismantled for the purposes of examining them, but also
encourages consideration of the relationships between dimensions [23]. The sociotechnical approach
encompasses a human factors engineering approach, which attempts to optimise users’ performance
of tasks whilst making allowances for human capabilities and limitations in complex environments
[27].
In recent times, it has become possible for Artificial Intelligence (AI), including Machine Learning
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(ML) algorithms, to underpin DHIs. ML algorithms analyse large datasets to detect patterns in data
[28]. They can generate predictive models, the outputs of which can support decision-making by
users [29]and include predictions of future risks. Effective communication of risk within a DHI must
take into account end users’ health literacy and numeracy  [30]. In addition, DHI interfaces should
adhere  to  evidence-based  recommendations  for  the  presentation  of  complex  risk  information  to
patients (e.g. use of plain language, use of absolute rather than relative risk) [30,26].
My Diabetes My Way (MDMW) [32,33] is a DHI (interactive website and app) for PWD and their
carers. It contains resources (including tailored information based on users’ own health/lifestyle data,
interactive educational resources and videos) as well as access to users’ clinical data. MDMW has
been used in Scotland since 2008 and has more recently (since 2018) been deployed in several NHS
Trusts in England (Somerset, NE London, Lancashire and South Cumbria, Cheshire and Merseyside
(where it is known as  MyWay Diabetes). MDMW takes a subset of data from primary and (where
possible) secondary care. These include key diabetes indicators (HbA1c, blood pressure, body mass
index) as well as eye and foot screening results, medication and clinical correspondence. It provides
users access to these records, as well as tailored advice and targeted resources based on each user’s
status. History graphs permit individuals to interrogate their data and progress over time. One area of
the  site  (Managing  your  condition page)  alerts  users  to  missed  screening  visits  (based  on  the
Diabetes  UK “15  Healthcare  Essentials”  [11]).  Patients  can  manually  enter  home-recorded  data
(weight, blood pressure, blood glucose), and set their own health and lifestyle goals. 
An AI-augmented version  of  MDMW is  being developed through linkage to  the  MyDiabetesIQ
(MDIQ)  analytics  and reporting  engine.  MDIQ is  linked to  a  knowledge base of  ~70 validated
machine learning models. It uses information from healthcare records (linkages with hospital/GP IT
systems)  and  home  recordings  (e.g.  Fitbit  activity  data  and  home  blood  glucose  data),  driving
predictive analytics. MDIQ models were developed in two ways: (a) Using individual literature-
published models;  and (b)  Meta-models  derived from literature-published models,  but delivering
improved  performance.  Models  were  revalidated  and  tested  in  Scottish  diabetes  datasets  (NHS
Greater  Glasgow  and  Clyde  (NHSGGC,  n=105k),  and  Northwest  London  datasets  (n  =  145k).
Proposed novel features underpinned by MDIQ include: presenting users with their predicted risk of
diabetes-related complications (based on their clinical and lifestyle data); allowing users to visualise
how lifestyle changes could impact their risk; and providing ongoing, tailored feedback on progress
toward users’ own goals. 
This study aims to provide an overview of the iterative design process of the enhanced interface of
this DHI and how human factors have informed system development using the sociotechnical model
as a theoretical framework  [22]. MDIQ AI models underpinning these additional features will be
described in greater detail in a separate publication.  
Methods 
Focus groups
Potential  focus group participants were identified via local patient and public involvement (PPI)
groups  whose  members  had  previously  expressed  an  interest  in  taking  part  in  diabetes-related
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research, and who had consented to being contacted. Initial email contact was made by local research
nurses.  Interested patients  were directed to  contact  the researcher  for further  information and to
complete  the  consent  process.  Two  of  the  authors  (CS  plus  one  other)  moderated  focus  group
sessions, which were held in meeting rooms within a local private venue or hospital. Sessions were
guided by an interview schedule (Appendix 1) and screenshots of early designs (for a new-look
Homepage, a Goal-setting area, and a novel Risk prediction tool). 
Focus  groups  were  audio  recorded  and  later  transcribed  verbatim.  NVivo  12  Software  (QSR
International  Ltd)  was  used  to  organise  and  code  the  textual  data,  which  were  analysed  using
inductive thematic analysis  [34]. In an effort to reduce bias, qualitative data were coded by two
authors (a researcher (CS) and a clinician (NC)). Any conflicts in coding decisions were reviewed by
both and resolved by discussion and consensus [35]. 
Where participants are quoted in the text, they are referred to by the number of the focus group they
attended and their participant number (e.g. FG1P1 = Focus Group 1, Participant 1), along with their
sex, age and diabetes type. 
NHS HRA Research Ethics Committee approvals were obtained (IRAS number: 258231).
Think aloud workshops
Focus group participants were invited back to attend workshops to user test a prototype site, the
development of which was guided by focus groups findings. Not all participants returned, so several
additional participants  were  recruited  from the  original  PPI  list.  Workshops  followed the  ‘think
aloud’ method  [36,37].  In this method, the participant is asked to explain their thinking, opinions,
actions and reactions as they perform several prescribed tasks [9]. Tasks given to users (Appendix 2)
represented common actions for which the system would eventually be used. Several tasks were
similar to actions that participants would be familiar  with when using the existing MDMW site.
Other tasks were novel, relating to unique  MDIQ-augmented features. All tasks were validated by
three of the authors (CS, LM and NC). 
Think aloud sessions took place in August 2020. Due to COVID-19 restrictions at the time of the
sessions, these were conducted remotely. A schematic of the set-up for remote user testing is shown
in Figure 1.  Each participant  was sent  a Blackboard Collaborate  link several days prior to  their
session. Blackboard Collaborate was chosen because no special software download was required by
participants, who could then easily screen share. Sessions were recorded by the moderators, with
participants’ screen  and  speech  captured  simultaneously.  Two  moderators  were  present  in  each
session: one (CS) introduced the activity, recorded the session and made notes; the other (LM) gave
instructions for think aloud tasks, and encouraged the participant to continue to speak if they became
quiet for too long.
Video recordings of sessions were later transcribed verbatim,  and each transcript annotated with
observations (e.g. position/activity of the user’s cursor). A combination of deductive and inductive
thematic analysis was employed  [34]. Text fragments relating to usability problems were mapped
onto all relevant dimensions of the sociotechnical model [22] (Human-computer interface; Clinical
content; Workflow and communication; People; Hardware and software), which became the major
themes. Within each of the dimensions, an inductive approach was used to identify subthemes that
were generated from the data. Qualitative data were coded by two authors (a researcher (CS) and a
clinician (NC)). Any conflicts in coding decisions were reviewed by both and resolved by discussion
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and consensus. [35] 
Where participants are quoted in the text, they are referred to by participant number (e.g. TA_P1),
along with their sex, age and diabetes type.
The think aloud component of the study was deemed to be ‘service evaluation’, and ethics approval was 
therefore not required.
Figure  1.  Schematic  showing  how  think  aloud  method  was  preformed  remotely,  using
Blackboard Collaborate Ultra for the meeting environment.
Results
Focus Groups
Focus group participant demographics
Two focus groups were conducted in Nov 2019 and Jan 2020 in two different regions of Scotland,
with a total of eight participants. In the first group there were two participants, and in the second, six.
Most participants were male (6 males, 2 females), a majority had Type 1 diabetes (T1D) (5 T1D, 3
T2D).  The mean age was 64 years (range 49-83 years) and the mean time since being diagnosed
was 22 years (range 5-58 years). The average recording length of focus group sessions was 64 min. 
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Figure 2. Themes and subthemes identified from focus group discussions
Themes and subthemes generated from focus group transcripts through inductive thematic analysis
are highlighted in Figure 2. These are discussed below in relation to  novel features  of the  MDIQ-
augmented site. 
i) Potential to empower users
Five of the eight participants felt  that some proposed new MDMW features had the potential to
empower users. For example, one novel feature described to participants during focus groups was the
potential for users to set their own goals via the system and then receive ongoing tailored feedback
on progress made toward goals. Two participants felt  that this could help to empower users. An
example of this sentiment is given below:
 “you’d set your weight goal and then say ‘every week I’m going to step on the scales’ and
then you’d put it in. It could be a useful tool as a specific thing.  Especially if your doctor has
wagged their finger at you…” (FG2P1; male, age 58, T1D)
In the case of a proposed new  Risk prediction tool,  which would display a user’s future risk of
developing  diabetes-related  complications  and  allow  them  to  alter  sliders  representing  lifestyle
choices to see how this impacts their risk, five participants felt that this had the potential to empower
users by arming them with information, allowing them to take control:
“you’ve got the recipient taking decisions and setting their own targets... That might go down
well with some folk. Very much so.” (FG1P2; male, age 83, T2D)
“…that’s what you want. With diabetes in particular, you want the patient to have control
themselves” (FG1P2; male, age 83, T2D)
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Those participants who were positive about the Risk prediction tool  saw it as a way of facilitating
users setting appropriate goals.
ii) Potential to elicit negative feelings
Despite the acknowledgement that users could be empowered by proposed features, six participants
also felt that these could have undesirable effects such as eliciting negative feelings, including users
becoming anxious or feeling as though they had ‘failed’. In the case of goal-setting with ongoing
feedback, there were concerns about the consequences if a user did not achieve their goals, and that
this might produce feelings of failure:
“I’m always wary about giving folk targets – what if they don’t make the target? There is a
consequence” (FG1P2; male, age 83, T2D)
 “I looked at it last night and it said ‘your height is this and your weight is that’. It says ‘you
are overweight’. Now I was overweight by 200g! You know? But it said ‘You are overweight.
You’ve failed. You’ve failed’. And that’s down to the language that’s in there.” (FG2P1; male,
age 58, T1D) [referring to how the current MDMW system reports the user’s current weight]
It was pointed out (by three participants) that goals should be ‘achievable’ and ‘safe’, and that some guidance
may be needed on what constitutes a realistic goal. This would help to mitigate against risks:
“Yes, because they could be setting themselves up for failure just by making it [the goal] unrealistic” 
(FG2P3; female, age 62, T1D)
“For those of us who are patients – we should agree the goal with the clinician. My goal is: ‘I want to 
shave down my HbA1c or lose a few pounds or drive down my cholesterol’ or whatever it might be. If 
they say ‘yes you could maybe do that in the next 4 months’ [sic]. I think it could be dangerous if you 
could randomly set your own goals” (FG2P1; male, age 58, T1D)
Although recognised as potentially empowering for users, the Risk prediction tool was seen (by four
participants) to have the potential to cause anxiety (or to exacerbate existing health anxieties) due to
users’ risks being revealed to them:
“You can have a toggle to say ‘I don’t want to see that’ but again if someone is worried – is a natural 
worrier – then they would click ‘yes - I want to see that kind of information’ and then it’s a positive - 
or a negative - feedback.” (FG1P1; male, age 62, T2D)
 
“If folk are prone to worry about things, it could make it worse. But for most of us we’re quite 
pragmatic about it when you’ve had diabetes for a while.” (FG2P5; female, age 49, T1D) 
Newly diagnosed users were regarded by several (four) participants as a special group, who may feel
more worried than other users when their future risks are revealed to them. However, it was also felt
that they could be the group who could benefit the most from this information:
“new folk – it might scare them a bit, but … you can’t have too much information” (FG2P5; female, 
age 49, T1D) 
“for newly diagnosed people, it would be really useful, and I would have found this - yes scary - but 
still giving me more information” (FG2P1; male, age 58, T1D) 
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iii) Language is important
In terms of mitigating any anxiety arising from using the  Risk prediction tool,  five of the eight
participants agreed that the use of positive and encouraging language would be vital:
“I think you have to say that because it is lifestyle parameters, all of those can be addressed.” (FG2P1;
male, age 58, T1D)
“Yes, so it’s not all doom and gloom. This is what it would look like if you carry on, but there
is a process for improving on that” (FG2P2; Male, age 66, T1D)
In order to further mitigate against anxiety about complications risk, three participants felt that users should 
be provided with extra guidance, such as information or a link alongside the Risk prediction tool, directing 
them to mental health advice or suggesting that they speak to their HCP if they are concerned about what 
they have seen:
“people choose whether to see that or not, but if they do choose to see it, and the results are
bad, then you could maybe put a link in or something to take them to the mental health
questionnaire” (FG1P1; male, age 62, T2D)
“How difficult would it be [for the site developers], if you’re on it and you want to click on a
link for support, like your diabetic nurse or your clinic?” (FG2P6; male, age 64, T2D)
iv) Look and feel of the site
The ‘look and feel’ of the site was also considered important by four of the participants. Discussions
on this theme fell into two subthemes: that images and icons would be preferable to large blocks of
text (or lists of data); and that navigation should be easy and intuitive:
“…you end up with a string of menus. You look for your own measurements – there’s eight or
nine of them, and you work your way down them, and ok by the time you get to number nine
you’re beginning to forget what was number one!” (FG1P2; male, age 83, T2D) [referring to
current MDMW site]
“If you were going into the front page with your five circles, and you tapped into one of the
reds,  and  you  got  your  graph,  that  would  make  sense”. (FG1P2;  male,  age  83,  T2D)
[responding to screen shots of possible new designs]
It was also felt (by two participants) that ‘jargon’ should be avoided as much as possible, and that any 
medical terms that are included should be accompanied by additional explanations: 
“So I think alongside each complication, you could have an explanation of what that is… It
should say what it specifically is – what it affects, I think it should give a bigger explanation”
(FG2P2; Male, age 66, T1D)
 “It needs to assume a low level of jargon knowledge” (FG2P1; male, age 58, T1D) 
Development of the prototype site
User perceptions and preferences collected during focus group discussions were considered and discussed by
the researcher (CS), several diabetes clinicians (NC and DW) and the lead platform developer (DB). Those that
were felt by all members of the team to be useful and feasible were incorporated into the prototype site. In 
this way, user insights directly influenced prototype site development. For example, participants’ desire for 
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clear visual cues and easy navigation was addressed by giving the homepage a ‘clean’ look, with coloured 
blocks (containing representative icons) for each test result/lifestyle item. When clicked, the blocks took the 
user to further details about each item. In comparison to the current MDMW site that participants were used
to, fewer clicks were required to reach frequently sought information (e.g. HbA1c history graphs; eye and 
foot screening results). 
Participants’ desire for positive language was also heeded. An example in the Risk prediction tool was the 
addition of a heading: “Let’s reduce your risk”. In response to participants’ demand for plain language (and 
for additional explanations where medical terms were necessary), diabetes-related complications in the Risk 
prediction tool were condensed into a single (combined) risk of developing complications, with an 
information icon alongside to explain what kinds of complications this pertains to. The positive reaction to 
the Risk prediction tool as a means of fostering suitable goals was harnessed by adding the option (via a 
button) to link outputs from this page to the Goal-setting area.
Think aloud sessions
Think aloud participant demographics
Seven participants took part in think aloud sessions with the prototype site.  Of these, most were
female (4 female, 3 male) and most had T1D (5 T1D, 2 T2D).  The mean age was 52 years (range
35-62  years) and mean time since diagnosis was  23 years, (range  4-37 years).  Sessions had an
average length of 41 minutes.
Thematic analysis
The 126 pertinent text fragments were mapped onto the five relevant sociotechnical model dimensions, 
which formed the basis of the major (deductive) themes of the analysis. Through an inductive approach, 
subthemes were generated from the data within each of the five dimensions. Some fragments coded into 
more than one thematic category, resulting in 136 fragments included in the analysis. Categories from the 
thematic analysis are summarised in Figure 3. 
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Figure 3. Thematic categories of think aloud transcript data. Major (deductive) themes were the five
relevant dimensions of the sociotechnical model. Subthemes were (inductive) themes within each
dimension that were generated from the data. 
Usability issues identified from think aloud user testing are summarised below and are discussed in relation 
to each of the sociotechnical model dimensions.
i) Human-computer interface
The majority (79) of text fragments from think aloud transcripts mapped onto the Human-computer interface
dimension of the sociotechnical model. Within this dimension, nine subthemes were identified (Figure 3). 
One of the most prevalent of these (with 17 text fragments) was Confusing visual cues. Examples include 
users not realising that an item on a page was clickable; and it not being obvious what the different areas of a
page represent: 
“As I hover over it, it’s ‘coming up’ which suggests it is clickable, but it’s not that obvious. I wouldn’t… 
it’s not that obvious.” (TA_P1; female, age 35, T1D) [referring to an object’s hover state]
“One of my first thoughts was: it's not obvious. It needs to say 'current' and then 'future'” (TA_P2; 
female, age 49, T1D) [referring to left- and right-hand sides of the Risk prediction tool page]
Another common theme (15 text fragments) within the Human-computer interface dimension was Unmet 
expectations. An example (in the Risk prediction tool) was the expectation by users to be able to select a 
value for lifestyle/clinical variables and type in a replacement value, rather than changing this using a slider:
“it doesn’t seem to highlight ‘HbA1c’. Now with the ‘smoking’ you had the wee bubble so you could 
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change it. And you had a slider bar for ‘activity’. But with ‘HbA1c’ you’ve got nothing, so I don’t know 
whether you click on it” (TA_P4; female, age 49, T1D)
Inconsistencies within the site was also a recurring theme within the Human-computer interface dimension (6
text fragments). An example was that some blocks on the homepage altered when hovered over (a shadow 
appeared around the edges), indicating to the user that they were clickable. Other blocks did not possess 
altered hover states, leading some users to assume these were not clickable. 
Some items were unresponsive, leading to several users becoming frustrated. An example was a slider in 
which the value did not change as the user moved the slider button along, and only refreshed once the 
button was released:
“Right so when you’re actually clicking on the slider, although you can move it, it’s not moving with 
the number.” (TA_P2; female, age 49, T1D)
“It doesn’t change as you move the slider. No… It’s very, very fiddly.” (TA_P4; female, age 49, T1D)
ii) Clinical content
Six participants expressed Confusion over who inputs data (i.e. whether it is the user or their healthcare team
who should do this). Within the Managing your condition page (a checklist of diabetes tests, checks and 
services that all people with diabetes should receive), some items (e.g. Have your legs and feet checked; 
Have your blood pressure measured) are automatically updated by the system once the user has attended a 
screening appointment, while others (e.g. Receive high quality care if admitted to hospital; Get emotional 
and psychological support) must be updated by the user. 
“I thought that someone at the clinic would be doing that for you… it would be quite nice to have 
something to say that that can be completed by the patient.” (TA_P5; female, age 51, T1D)
Within Clinical content, there was also a subtheme of Expected data not being present. For example, two 
participants expected access to retinal scan images via the Retinal status page.
iii) Workflow and communication
Three of the participants wrongly expected that their HCP would be notified when they entered data into the
system. For example, within the Managing your condition page, the user can tick ‘Received’ or ‘Not received’ 
alongside a checklist item such as Get emotional and psychological support.  Some users incorrectly assumed 
that ticking ‘not received’ would alert their GP that they needed further support. This is not the case – the 
checklist is intended to serve only as a reminder for the user:
“So basically it gives the patient an opportunity to ask for something which they think could be useful
to them” (TA_P3; male, age 62, T2D)
iv) People
Four participants pointed out that users with limited digital skills might find it challenging to interact with 
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some aspects of the DHI. This was mentioned in relation to using the Risk prediction tool (which involves the 
user interacting with several sliders and toggles and interpreting risk prediction outputs), as well as in 
relation to navigating from the homage to other pages, as in the following example:
“having green boxes and red boxes is really good. I’m all for colours and highlighting things. 
Especially for people who are not as tech savvy, as I am not.” (TA_P4; female, age 49, T1D) 
Sentiments that the Risk prediction tool could potentially cause anxiety, which had been expressed during 
focus groups, were reiterated by some (four) think aloud participants:
“It might put a lot of pressure on some people because it's not as easy to change your HbA1c as just 
moving a slider” (TA_P5; female, age 51, T1D)
“It's important it’s not rolled out to some patients who have a high risk and who have little or no 
opportunity to address that.” (TA_P6; male, age 58, T1D)
Two participants commented that additional information that appears beneath page titles (e.g. HbA1c page, 
Weight and BMI page) explaining these medical/lifestyle terms were superfluous and could make users feel 
‘patronised’:
“The banner headline at the top. It's very patronising. Stating the bleeding obvious, you
know? For anyone who's been diagnosed for a while and has a bit of understanding about the 
condition.” (TA_P6; male, age 58, T1D)
v) Hardware and software
Three text fragments referred to users’ experience of the site being dependent on the device they use. One 
example is a list of screening results that appeared at the bottom of the Retinal status page, which one 
participant felt might be missed by someone accessing the site using a mobile phone:
“Unless you know to scroll down you might miss that bit about retinopathy. I suppose if you were 
looking on a phone, as well, you might not see that”. (TA_P5; female, age 51, T1D)
Development of the final site
User insights gained from focus groups and think aloud workshops with the prototype site were discussed 
among the researcher, clinicians and developer (CS, NC, DW, DB), and those that were feasible were used to 
inform the development of the final (live) MDIQ-augmented MDMW site. Resulting changes included the use
of more positive and encouraging language throughout the site, and mitigating users’ anxieties. An example 
of the latter is a line of text added to the Risk prediction tool suggesting that the user talk to their healthcare 
team if they are concerned about anything they have seen (table 1). A user’s risk of developing complications
will be presented as a single ‘combined risk’, with a breakdown of what those complications are (for users 
who wish to find out more). A simple explanation of what probability means will also be explained in a text 
box via an information icon (Table 1). A video will be added alongside the Risk prediction tool, explaining how
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to use the tool, defining the terms used within the tool, and what the outputs mean. This will assist users 
with low digital and health literacy, and will satisfy the need for plain language. The Risk prediction tool will 
be displayed only after a new user’s third visit to the MDMW site, allowing newly diagnosed users to become
familiar with the site (and with having diabetes) before being presented with their complications risk 
forecast.
In the final site, if a user saves the lifestyle settings in the Risk prediction tool as goals, these will be saved to 
the Goal-setting area of the site. within the Goal-setting area, such goals will appear alongside links to 
resources on setting achievable goals, as well as links to targeted education resources (e.g. resources on 
smoking cessation for those who set a goal to ‘give up smoking’).
Several examples of unclear visual cues have been addressed in the final site. Within the Risk prediction tool, 
the representation of ‘current risk’ on the left-hand side of the Risk prediction tool and potential ‘future risk’ 
on the right-hand side, which had been unclear to several think aloud participants, has been made explicit 
(left side smaller, clear labels above each side). Signposting to sliders within the Risk prediction tool has also 
been improved (table 1). Sliders have been made more consistently styled, and more responsive (changing in
real time as the slider button is dragged) in comparison with those in the prototype site.
Table 1. Examples of how insights gained during focus groups and think aloud workshops informed the 
development of the final MDIQ-augmented MDMW site. 
Insight from focus groups/think aloud
workshops
Resulting change in live MDIQ-
augmented site
User being shown their risk of developing 
diabetes-related complications could 
cause anxiety.
Addition of text box to the Risk prediction 
tool:
Plain language needed, explain terms 
used
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Information icon text, when clicked:
Clearer instructions needed e.g. addition of text directly above the 
sliders on the Risk prediction tool:
Discussion
This study has demonstrated that end user involvement at each iterative stage of the design of a DHI
can help to prioritise users’ requirements throughout the design process. This novel version of an
existing  DHI  for  diabetes  (MDMW)  will  be  underpinned  by  a  ML  engine  (MDIQ).  Before
developing a prototype interface, developers were made aware of user perceptions and preferences
collected during initial focus groups. The resulting prototype was then user tested through the think
aloud method, leading to the development of a new live MDIQ-augmented MDMW site, soon to be
released. This work paves the way for a future iteration of this user-centred design process, which
will entail large-scale real-world testing of the live site. 
The sociotechnical model used here as a framework for the thematic analysis of think aloud data [22]
needed  to  be  adapted,  with  three  of  the  model  dimensions  (Internal  organisational  policies,
procedures,  culture  and  environment;  External  rules,  regulations  and  pressures;  System
measurement and monitoring) not being relevant in the context of this patient-facing DHI. These
dimensions are more applicable in clinician-facing Health Information Technology used in formal
healthcare  settings,  in  which  the  model  was  originally  conceived  [22].  Think  aloud  data  were
therefore mapped onto the remaining five dimensions of the model (Human-computer interface;
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Clinical content; Workflow and communication; People; Hardware and software), and subthemes
were generated from the data.
It is useful to consider our findings in relation to each of the dimensions of the sociotechnical model 
individually. However, there is much interplay between dimensions. For example, many of the subthemes 
described within the Human-computer interactions dimension (e.g. unclear visual cues; unclear instructions) 
would be compounded for a user who has limited digital skills (People dimension). Confusion over who 
inputs data (Clinical dimension) could be avoided by addressing issues around Human-computer interactions 
(i.e. including visual cues and instructions). Understanding the connections between the model dimensions 
can help developers find solutions that don’t focus on one dimension while ignoring the impact of a given 
solution on others (unintended consequences) [38]. This can additionally help developers to understand the 
wider sociotechnical structures already in place that could aid or constrain adoption of the technology under 
development [23] (e.g. realising that cues that might be obvious to users who are used to interacting with 
online platforms may not be obvious to less technically literate). Awareness of these interactions between 
dimensions can help to make the site more usable for all users.
Main findings
This  study has  demonstrated that  viewing usability  problems through a sociotechnical  lens,  and
considering links between sociotechnical dimensions, can help to foster the development of a more
acceptable DHI. Findings from prototype usability testing are being used to inform development of
the  final  site  e.g.  when  an  unclear  visual  cue  was  identified  (Human  Computer  Interactions
dimension),  it  was  amended  to  address  concerns  regarding  digital  literacy  (People dimension).
Similarly, users expressed some confusion regarding which data items were updated automatically
and which were to be completed by the user (Clinical dimension), and which self-entered data items
were fed back to the healthcare team (Workflow and communication dimension).  The user interface
will be amended to clarify both and to mitigate against clinical risk.
This study found that participants were more receptive to users setting goals based on the outputs generated
by the Risk prediction tool than they were to straightforward goal setting (where a user simply sets a goal for 
themselves) (Potential to empower users theme). Some participants were concerned about users setting 
‘unrealistic’ goals, thereby ‘setting themselves up for failure’, or setting ‘unsafe’ goals (People dimension). In 
response, the DHI now incorporates a link to goal setting within the Risk prediction tool, and has been 
amended to highlight the need to set achievable goals, with the aim to provide a ‘scaffold’ to foster healthy 
goals, whilst aligning these goals with the user’s accepted level of risk of diabetes complications. 
Participant desires may not always be actionable, particularly when they rely on third parties whose working 
practices cannot be dictated by the DHI developers; for example validation and approval of all user-set goals 
by clinicians was deemed desirable by some participants but would require clinicians to have extra time and 
flexibility in their working practices to facilitate this (Workflow and communication dimension). 
The possibility of the system offering ongoing feedback on progress toward user-set goals was suggested to 
focus group participants.  The platform will continue to be developed with the potential to incorporate goal-
setting notifications and alerts via email and mobile devices in the future. Any such developments will need 
to address participants’ concerns regarding the potential to induce anxiety or feelings of failure in the event 
of a goal not being achieved.
During focus group discussions, most participants expressed a need for ‘plain language’ (avoidance of 
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medical jargon), as well as the addition of explanations alongside medical terms. This informed the decision 
to condense the initial information given to users, with additional information accessed via an information 
icon. There were, however, contrasting views around annotating items with further explanations, with some 
users feeling “patronised”.  PWD are a diverse group, and preferences will differ amongst individuals.  For 
example, the needs of someone with longstanding diabetes will likely differ from someone who is newly 
diagnosed (participants identified this latter group as having a lot to gain from the platform).  MDMW already
encompasses some degree of tailoring (e.g. diabetes type, cholesterol and blood pressure). Further tailoring 
(e.g. user preference, diabetes duration etc.) is technically possible, although there is the potential that in 
doing so the platform may become overly complicated.
Limitations of the investigation
Attempts to recruit a more diverse group of participants via purposive sampling were not realised
owing to poor response rates to the initial invite.  The number of participants was relatively small
and skewed towards older people with T1D who have had diabetes for many years.  However, due to
the  rich  data  it  delivers,  the  think  aloud  method  requires  only  small  numbers  of  participants
(suggested  n=5-8)  to  uncover  a  high  proportion  of  usability  problems  [9].   In  addition,  the
participants were all considered “expert patients”, whose experience provided valuable insights.
Social distancing necessitated by the COVID-19 pandemic resulted in the use of remote online user
testing.   This  approach  has  known  disadvantages,  such  as  moderators  needing  to  deal  with
unexpected  technical  issues  during  sessions,  and  participants  potentially  facing  a  cognitively
demanding environment  (i.e.  navigating  a  video conferencing tool  as  well  as  testing  the  online
intervention  in  question)[39].   Efforts  were  made  to  minimise  these  issues  by  giving  clear
instructions prior to sessions and by reassuring participants during sessions.  In addition, remote
online  user  testing  provides  several  potential  benefits:  participants  can  be  observed  using  the
intervention  in  a  more  authentic  context  compared  with  sitting  in  a  lab  with  researchers;  and
participants have more control over the session than they would in a lab setting (e.g. muting their
audio) [39]. 
Conclusion
This study demonstrates that acting on the input of end users at each stage of development can help
to  build  more  acceptable  DHIs,  aligning  features  to  users’  needs  and  avoiding  unintended
consequences that might cause disengagement. Good control of diabetes already relies heavily on
self-management.  The disruption of clinical services secondary to the COVID-19 pandemic only
served  to  accentuate  this.  Digital  tools  such  as  MDMW (and  particularly  the  MDIQ-enhanced
version now being developed) can offer personalised support for self-management, alongside access
to patients’ electronic health records in a user-friendly environment. These features can facilitate self-
management,  thereby  reducing  users’  risk  of  developing  diabetes-related  complications  (with
potential  significant  reductions  in  healthcare costs.).   This  study serves  as an exemplar  of user-
centred design that will ensure that MDMW is relevant and usable for people with diabetes.
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Appendix 1. Focus group schedule
1. How frequently do you use MDMW and what is the main reason you usually visit?
2. If you were to set a goal (e.g. to lose weight), would it appeal to have regular messages about
your progress towards that goal (based on your data within the system)?
3. Would you want to be made aware of your risks of developing diabetes-related complications
in the future? How would it make you feel to see your risks presented to you on the screen?
4. If  there were a  section of  the  site  where  you could visualise  your  lifestyle  choices  (e.g.
weight/smoking  status/HbA1c/cholesterol  levels/activity  levels)  and  see  the  impacts  of
making changes to these on your risk of complications in the future, would this help you with
e.g. setting goals?
5. How should things be worded when talking to users about risk?
6. Can you identify any risks of using MDMW with the new features we’ve discussed? If so,
how might these risks be mitigated?
7. Is there anything that would deter you from using the new features we’ve discussed?
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Appendix 2. Tasks evaluated in the think aloud sessions
1. Locate and examine your HbA1c history graph
2. Find the page where you would add a weight measurement. Add a new weight measurement
of 90kg
3. Locate the page where you can set a new goal for cholesterol. Add a goal of 3.5 mmol/L to be
reached by [future date]
4. Locate the retinal status page. Check what your retinal status was on [date in the past]
5. Find the ‘Managing your condition’ page – explore and comment on this page
6. In the Risk prediction tool, find out what your risk of complications would be in 5 years, if
your smoking status were to change from ‘smoking’ to ‘non-smoking’; your activity level
were to change from ‘low’ to ‘medium’; and your HbA1c was brought down to 48 mmol/mol
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Schematic showing how think aloud method was preformed remotely, using Blackboard Collaborate Ultra as a meeting
environment.
https://preprints.jmir.org/preprint/29973 [unpublished, peer-reviewed preprint]
JMIR Preprints Shields et al
Themes and subthemes identified from focus group discussions.
https://preprints.jmir.org/preprint/29973 [unpublished, peer-reviewed preprint]
JMIR Preprints Shields et al
Thematic categories of think aloud transcript data. Major (deductive) themes were the five relevant dimensions of the
sociotechnical model. Subthemes were (inductive) themes within each dimension that were generated from the data.
https://preprints.jmir.org/preprint/29973 [unpublished, peer-reviewed preprint]
JMIR Preprints Shields et al
Multimedia Appendixes
https://preprints.jmir.org/preprint/29973 [unpublished, peer-reviewed preprint]





Powered by TCPDF (www.tcpdf.org)
https://preprints.jmir.org/preprint/29973 [unpublished, peer-reviewed preprint]
